Anthony Vendetti
Stock Analyst at Maxim Group
(3.44)
# 890
Out of 5,182 analysts
84
Total ratings
27.03%
Success rate
12.86%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSF Laird Superfood | Maintains: Buy | $8 → $6 | $3.33 | +80.18% | 2 | Mar 30, 2026 | |
| AMIX Autonomix Medical | Maintains: Buy | $5 → $2 | $0.36 | +454.02% | 2 | Feb 17, 2026 | |
| SRTS Sensus Healthcare | Maintains: Buy | $8 → $6 | $3.96 | +51.52% | 7 | Feb 17, 2026 | |
| HLF Herbalife | Initiates: Buy | $20 | $16.46 | +21.51% | 1 | Jan 6, 2026 | |
| BRFH Barfresh Food Group | Maintains: Buy | $5 → $6 | $2.55 | +135.29% | 3 | Sep 19, 2025 | |
| NMTC NeuroOne Medical Technologies | Initiates: Buy | $18 | $4.61 | +290.46% | 1 | Sep 9, 2025 | |
| NUTX Nutex Health | Maintains: Buy | $225 → $205 | $110.79 | +85.03% | 6 | Aug 26, 2025 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $30 → $10 | $1.21 | +726.45% | 5 | Aug 21, 2025 | |
| CELH Celsius Holdings | Maintains: Buy | $50 → $65 | $33.14 | +96.14% | 8 | Aug 8, 2025 | |
| NEPH Nephros | Maintains: Buy | $4.5 → $6 | $3.23 | +85.76% | 1 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $0.93 | +437.75% | 8 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.21 | - | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $0.41 | +1,134.57% | 3 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $4.38 | +173.98% | 1 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.37 | - | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $8 | $0.79 | +916.52% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.12 | - | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $900 | $8.09 | +11,024.85% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $14.13 | -29.23% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $0.85 | +491.23% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $0.97 | +2,374.23% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $9.08 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $0.83 | +140.67% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,250 | $3.81 | +32,708.40% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $175 | $7.00 | +2,400.00% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $32.99 | -24.21% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60,000 → $35,000 | $0.52 | +6,748,839.45% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.17 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.74 | - | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.28 | +956.34% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $22.65 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $34.27 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.60 | +120,200.75% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.94 | -54.30% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.29 | - | 1 | May 31, 2016 |
Laird Superfood
Mar 30, 2026
Maintains: Buy
Price Target: $8 → $6
Current: $3.33
Upside: +80.18%
Autonomix Medical
Feb 17, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $0.36
Upside: +454.02%
Sensus Healthcare
Feb 17, 2026
Maintains: Buy
Price Target: $8 → $6
Current: $3.96
Upside: +51.52%
Herbalife
Jan 6, 2026
Initiates: Buy
Price Target: $20
Current: $16.46
Upside: +21.51%
Barfresh Food Group
Sep 19, 2025
Maintains: Buy
Price Target: $5 → $6
Current: $2.55
Upside: +135.29%
NeuroOne Medical Technologies
Sep 9, 2025
Initiates: Buy
Price Target: $18
Current: $4.61
Upside: +290.46%
Nutex Health
Aug 26, 2025
Maintains: Buy
Price Target: $225 → $205
Current: $110.79
Upside: +85.03%
Dermata Therapeutics
Aug 21, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $1.21
Upside: +726.45%
Celsius Holdings
Aug 8, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $33.14
Upside: +96.14%
Nephros
Aug 8, 2025
Maintains: Buy
Price Target: $4.5 → $6
Current: $3.23
Upside: +85.76%
May 8, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $0.93
Upside: +437.75%
Apr 1, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.21
Upside: -
Mar 24, 2025
Upgrades: Buy
Price Target: $5
Current: $0.41
Upside: +1,134.57%
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $4.38
Upside: +173.98%
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.37
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $0.79
Upside: +916.52%
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.12
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $900
Current: $8.09
Upside: +11,024.85%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $14.13
Upside: -29.23%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $0.85
Upside: +491.23%
Oct 5, 2023
Initiates: Buy
Price Target: $24
Current: $0.97
Upside: +2,374.23%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $9.08
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $0.83
Upside: +140.67%
Apr 20, 2023
Initiates: Buy
Price Target: $1,250
Current: $3.81
Upside: +32,708.40%
Mar 31, 2023
Maintains: Buy
Price Target: $300 → $175
Current: $7.00
Upside: +2,400.00%
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $32.99
Upside: -24.21%
Mar 23, 2023
Maintains: Buy
Price Target: $60,000 → $35,000
Current: $0.52
Upside: +6,748,839.45%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.17
Upside: -
Nov 14, 2022
Downgrades: Hold
Price Target: n/a
Current: $3.74
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.28
Upside: +956.34%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $22.65
Upside: -
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $34.27
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.60
Upside: +120,200.75%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.94
Upside: -54.30%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $11.29
Upside: -